Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women
At 6 months, a cohort of 8,127 women in the UK initiating GLP-1 receptor agonist therapy via a digital platform showed mean weight reduction comparable to that in randomized clinical trials.